CAPÍTULO 2: Nomenclatura, diagnóstico y clasificación de la espondiloartritis axial

  • Rodrigo García Salinas Hospital Italiano de La Plata, Provincia de Buenos Aires, Argentina
  • Hernán Maldonado-Ficco Hospital San Antonio de Padua, Río Cuarto, Córdoba, Argentina
  • José A Maldonado-Cocco Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina
Palabras clave: espondiloartritis, espondilitis anquilosante, espondiloartritis axial, nomenclatura, diagnóstico, clasificación

Resumen

Las espondiloartritis (EspA), espondilitis anquilosante (EA), artritis psoriásica, artritis reactiva y artritis asociada a enfermedad inflamatoria intestinal, son un grupo de enfermedades que comparten características clínicas, genéticas e imagenológicas. A su vez las espondiloartritis pueden clasificarse según el compromiso esquelético sea axial o periférico en EspAax o EspAp respectivamente.

Biografía del autor/a

Rodrigo García Salinas, Hospital Italiano de La Plata, Provincia de Buenos Aires, Argentina
Hospital Italiano de La Plata
Hernán Maldonado-Ficco, Hospital San Antonio de Padua, Río Cuarto, Córdoba, Argentina
Hospital San Antonio de Padua
José A Maldonado-Cocco, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina
Universidad de Buenos Aires

Citas

I. Dougados M, Baeten D. Spondyloarthritis. Lancet. 2011;377(9783):2127-2137.

II. Calin A, Porta J, Fries JF, Schurman DJ. Clinical history as a screening test for ankylosing spondylitis. JAMA. 1977;237(24):2613-2614.

III. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27(4):361-368.

IV. Amor B, Dougados M, Mijiyawa M. Criteria of the classification of spondylarthropathies. Revue du rhumatisme et des maladies osteo-articulaires. 1990;57(2):85-89.

V. Dougados M, Linden S van der, Juhlin R, Huitfeldt B, Amor B, Calin A, et al. The European Spondylarthropathy Study Group Preliminary Criteria for the Classification of Spondylarthropathy. Arthritis & Rheumatism. 1991;34(10):1218-1227.

VI. Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): Validation and final selection. Ann Rheum Dis. 2009;68(6):777-783.

VII. Hayward RJ, Machado PM. Classification criteria in axial spondyloarthritis: what have we learned. Where are we going? Rheum Dis Clin North Am. 2020;46(2):259-274.

VIII. Rudwaleit M, Landewe R, van der Heijde D, Listing J, Brandt J, Braun J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis. 2009;68(6):770-776.

IX. Maksymowych WP. The role of imaging in the diagnosis and management of axial spondyloarthritis. Nat Rev Rheumatol. 2019;15(11):657-672.

X. Rudwaleit M, Khan MA, Sieper J. The challenge of diagnosis and classification in early ankylosing spondylitis: Do we need new criteria? Arthritis Rheum. 2005;52(4):1000-1008.

XI. Sieper J, van der Heijde D. Review: Nonradiographic axial spondyloarthritis: New definition of an old disease? Arthritis Rheum. 2013;65(3):543-551.

XII. Deodhar A, Strand V, Kay J, Braun J. The term ‘non-radiographic axial spondyloarthritis’ is much more important to classify than to diagnose patients with axial spondyloarthritis. Ann Rheum Dis. 2016;75(5):791-794.

XIII. Rudwaleit M, Metter A, Listing J, Sieper J, Braun J. Inflammatory back pain in ankylosing spondylitis: A reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum. 2006;54(2):569-578.

XIV. Sieper J, van der Heijde D, Landewé R, Brandt J, Burgos-Vagas R, Collantes-Estevez E, et al. New criteria for inflammatory back pain in patients with chronic back pain: A real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis. 2009;68(6):784-788.

XV. van den Berg R, de Hooge M, Rudwaleit M, Sieper J, van Gaalen F, Reijnierse M, et al. ASAS modification of the Berlin algorithm for diagnosing axial spondyloarthritis: Results from the SPondyloArthritis Caught Early (SPACE)-cohort and from the Assessment of SpondyloArthritis international Society (ASAS)-cohort. Ann Rheum Dis. 2013;72(10):1646-1653.

XVI. de Winter JJ, van Mens LJ, van der Heijde D, Landewé R, Baeten DL. Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis. Arthritis Res Ther. 2016;18(1):196.

XVII. Rademacher J, Poddubnyy D, Pleyer U. Uveitis in spondyloarthritis. Therapeutic Advances in Musculoskeletal Disease. J Mol Med (Berl). 2020;98(1):71-95.

XVIII. Stolwijk C, van Tubergen A, Castillo-Ortiz JD, Boonen A. Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74(1):65-73.

XIX. Spoorenberg A, van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H, et al. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol. 1999;26(4):980–984.

XX. Garrido-Cumbrera M, Poddubnyy D, Gossec L, Gálvez-Ruiz D, Bundy C, Mahapatra R, et al. The European Map of Axial Spondyloarthritis: Capturing the Patient Perspective- an Analysis of 2846 Patients Across 13 Countries. Curr Rheumatol Rep. 2019;21(5):19.

XXI. Garrido‐Cumbrera M, Bundy C, Navarro‐Compán V, Makri S, Sanz‐Gómez S, Christen L, et al. Patient‐reported impact of axial spondyloarthritis on working life: results from the European map of axial spondyloarthritis survey. Arthritis Care Res. 2021;73(12):1826-1833.

XXII. López-Medina C, Ramiro S, van der Heijde D, Sieper J, Dougados M, Molto A. Characteristics and burden of disease in patients with radiographic and non-radiographic axial Spondyloarthritis: a comparison by systematic literature review and meta-analysis. RMD Open. 2019;5(2):e001108.

XXIII. Ramiro S, Landewé R, van Tubergen A, Boonen A, Stolwijk C, Dougados M, et al. Lifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis: a longitudinal analysis. RMD Open. 2015;1(1):e000153.

XXIV. Ramiro S, van der Heijde D, van Tubergen A, Stolwijk C, Dougados M, van den Bosch F, et al. Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort. Ann Rheum Dis. 2014;73(8):1455-61.

XXV. Poddubnyy D, Rudwaleit M, Haibel H, Listing J, Marker-Hermann E, Zeidler H, et al. Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis. Ann Rheum Dis. 2011;70(8):1369-1374.

XXVI. Poddubnyy D, Protopopov M, Haibel H, Braun J, Rudwaleit M, Sieper J. High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort. Ann Rheum Dis. 2016;75(12):2114-2118.

XXVII. Deodhar A, Reveille JD, van den Bosch F, Braun J, Burgos-Vargas R, Caplan L, et al. The Concept of Axial Spondyloarthritis: Joint Statement of the Spondyloarthritis Research and Treatment Network and the Assessment of SpondyloArthritis international Society in Response to the US Food and Drug Administration’s Comments and Concerns. Arthritis Rheumatol. 2014;66(10):2649-2656.

XXVIII. Poddubnyy D. Classification vs diagnostic criteria: the challenge of diagnosing axial spondyloarthritis. Rheumatology. 2020;59(Suppl4):iv6-iv17.

XXIX. Moltó A, Paternotte S, van der Heijde D, Claudepierre P, Rudwaleit M, Dougados M. Evaluation of the validity of the different arms of the ASAS set of criteria for axial spondyloarthritis and description of the different imaging abnormalities suggestive of spondyloarthritis: data from the DESIR cohort. Ann Rheum Dis. 2015;74(4):746-751.

XXX. García Salinas R, Ruta S, Chichande JT, Prado ES, Ruta A, Salvatori F, et al. “Reuma-Check”: Performance of a Comprehensive Fast-Track Program for the Diagnosis of Axial Spondyloarthritis in South America. J Clin Rheumatol. 2021;27(5):175-181.

XXXI. Salinas RG, Paula M, Bosch G, Martire V, Arturi P, Magri S. La resonancia magnética en el estudio de lumbalgia. Un análisis de la oportunidad perdida para el diagnóstico de espondiloartritis axial. Rev argent reumatol. 2017; 28(3): 15-19.

XXXII. Poddubnyy D, Callhoff J, Spiller I, Listing J, Braun J, Sieper J, et al. Diagnostic accuracy of inflammatory back pain for axial spondyloarthritis in rheumatological care. RMD Open. 2018;4(2):e000825.

XXXIII. López-Medina C, Molto A, Sieper J, Duruöz T, Kiltz U, Elzorkany B, et al. Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study. RMD Open. 2021;7(1):e001450.

XXXIV. Schett G, Lories RJ, D’Agostino M-A, Elewaut D, Kirkham B, Soriano ER, et al. Enthesitis: from pathophysiology to treatment. Nat Rev Rheumatol. 2017;13(12):731-741.

XXXV. Rudwaleit M, Haibel H, Baraliakos X, Listing J, Märker-Hermann E, Zeidler H, et al. The early disease stage in axial spondylarthritis: Results from the German spondyloarthritis inception cohort. Arthritis Rheum. 2009;60(3):717-727.

XXXVI. van Lunteren M, van der Heijde D, Sepriano A, Berg IJ, Dougados M, Gossec L, et al. Is a positive family history of spondyloarthritis relevant for diagnosing axial spondyloarthritis once HLA-B27 status is known? Rheumatology. 2019;58(9):1649–1654.

XXXVII. Khan MA. HLA-B27 and its subtypes in world populations. Curr Opin Rheumatol. 1995;7(4):263-269.

XXXVIII. Colombres F, Berman A, Berman H, Spindler A S, G. WC. Antígeno leucocitario humano (HLA) B27 y otras variantes alélicas del locus B en pacientes con espondiloartritis temprana en Argentina. Rev Arg Reumatol. 2014;25.

XXXIX. Benegas M, Muñoz-Gomariz E, Font P, Burgos-Vargas R, Chaves J, Palleiro D, et al. Comparison of the clinical expression of patients with ankylosing spondylitis from Europe and Latin America. J Rheumatol. 2012;39(12):2315-20.

XL. García-Salinas R, Ruta S, Chichande JT, Magri S. The Role of HLA-B27 in Argentinian Axial Spondyloarthritis Patients. J Clin Rheumatol. 2022;28(2):e619-e622.

XLI. Zabotti A, Luchetti MM, Selmi CF, Ramonda R, Grembiale RD, Dagna L, et al. An Italian Disease-Based Registry of Axial and Peripheral Spondyloarthritis: The SIRENA Study. Front Med. 2021;8:711875.

XLII. Rudwaleit M, van der Heijde D, Khan MA, Braun J, Sieper J. How to diagnose axial spondyloarthritis early. Ann Rheum Dis. 2004;63(5):535-43.

XLIII. Mandl P, Navarro-Compán V, Terslev L, Aegerter P, van der Heijde D, D’Agostino MA, et al. EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice. Ann Rheum Dis. 2015;74(7):1327-1339.

XLIV. Rudwaleit M, Jurik AG, Hermann KGA, Landewé R, van der Heijde D, Baraliakos X, et al. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: A consensual approach by the ASAS/OMERACT MRI group. Ann Rheum Dis. 2009;68(10):1520-1527.

XLV. Maksymowych WP, Lambert RG, Østergaard M, Pedersen SJ, Machado PM, Weber U, et al. MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group. Ann Rheum Dis. 2019;78(11):1550-1558.

XLVI. de Winter J, de Hooge M, van de Sande M, de Jong H, van Hoeven L, de Koning A, et al. Magnetic Resonance Imaging of the Sacroiliac Joints Indicating Sacroiliitis According to the Assessment of SpondyloArthritis international Society Definition in Healthy Individuals, Runners, and Women With Postpartum Back Pain. Arthritis Rheumatol. 2018;70(7):1042-1048.

XLVII. Garcia Salinas R, Marin J, Aguilar G, Ruta S, Aguerre D, Baraliakos X. Recognition of spondyloarthritis lesions on magnetic resonance imaging: Results of an educational intervention. Int J Rheum Dis. 2020;23(12):1651-1655.

XLVIII. Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: A guide to assess spondyloarthritis. Ann Rheum Dis. 2009;68 Suppl 2:ii1-44.

Publicado
2024-07-01
Cómo citar
1.
García Salinas R, Maldonado-Ficco H, Maldonado-Cocco JA. CAPÍTULO 2: Nomenclatura, diagnóstico y clasificación de la espondiloartritis axial. Rev. Argent. Reumatol. [Internet]. 1 de julio de 2024 [citado 6 de diciembre de 2024];35(Sup1):13 -22. Disponible en: https://ojs.reumatologia.org.ar/index.php/revistaSAR/article/view/823